+49 1521 6613828
caslinkllc@gmail.com
USD 7,999.00 - 9,999.00 / Piece
| Business Type | Manufacturer, Exporter, Supplier |
| Payment Terms | T/T, Western Union |
Polivy (polatuzumab vedotin-piiq) is a medication indicated in combination with bendamustine and a rituximab product for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma, not otherwise specified, after at least two prior therapies. Diffuse large B-cell lymphoma is a type of non-Hodgkin lymphoma.
Looking for "Polivy (polatuzumab vedotin-piiq)" ?
Piece
Explore More Products
